Esperion Therapeutics Inc (ESPR)
R&D Expenses
$44.28M
TTM · Period ending: · USD
ESPR R&D Expenses
Latest reported$44.28Mperiod ending
Latest reported$44.28Mperiod ending
ESPR TTM R&D Expenses ($21.79M → $44.28M)
TTM R&D Expenses
High-resolution chart · PNG
ESPR r&d expenses history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | R&D Expenses (USD) |
|---|---|
| 44,283,000 | |
| 47,852,000 | |
| 44,903,000 | |
| 41,169,000 | |
| 45,392,000 | |
| 46,238,000 | |
| 53,003,000 | |
| 57,491,000 | |
| 68,129,000 | |
| 86,107,000 | |
| 101,398,000 | |
| 115,656,000 | |
| 125,989,000 | |
| 118,927,000 | |
| 113,510,000 | |
| 109,698,000 | |
| 102,340,000 | |
| 105,975,000 | |
| 120,323,000 | |
| 130,275,000 | |
| 140,188,000 | |
| 146,936,000 | |
| 143,206,000 | |
| 156,204,000 | |
| 164,005,000 | |
| 175,611,000 | |
| 186,850,000 | |
| 180,120,000 | |
| 176,856,000 | |
| 171,488,000 | |
| 155,454,000 | |
| 153,959,000 | |
| 152,683,000 | |
| 147,603,000 | |
| 139,045,000 | |
| 112,487,000 | |
| 83,937,000 | |
| 57,868,000 | |
| 40,943,000 | |
| 34,692,000 | |
| 32,203,000 | |
| 29,802,000 | |
| 28,046,000 | |
| 27,973,000 | |
| 27,292,000 | |
| 25,302,000 | |
| 26,440,517 | |
| 22,749,190 | |
| 19,321,612 | |
| 16,014,205 | |
| 10,329,970 | |
| 9,303,709 | |
| 8,533,510 | |
| 7,998,128 | |
| 10,816,846 | |
| 14,632,434 | |
| 17,762,211 | |
| 21,197,000 | |
| 22,140,000 | |
| 21,746,000 | |
| 21,991,000 | |
| 22,150,000 | |
| 21,636,000 | |
| 21,149,000 | |
| 21,048,000 | |
| 20,819,000 | |
| 22,618,000 | |
| 23,330,000 | |
| 21,789,357 |